|
| 九洲药业(603456)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2023-09-28 | 54.09 | 0.06% | 89810.68 | 138.55 | 89756.59 | 99.79% | 股权激励限售股份 | | 2023-08-18 | 34.83 | 0.04% | 89756.59 | 192.64 | 89721.76 | 99.75% | 股权激励限售股份 | | 2023-07-20 | 6529.12 | 7.26% | 89721.76 | 232.81 | 83192.64 | 92.48% | 定向增发机构配售股份 | | 2023-06-12 | 68.72 | 0.08% | 83192.64 | 6761.93 | 83123.92 | 92.41% | 股权激励限售股份 | | 2022-11-25 | 54.57 | 0.07% | 83123.92 | 301.53 | 83123.92 | 99.64% | 股权激励限售股份 | | 2022-08-10 | 46.44 | 0.06% | 83069.35 | 360.72 | 83069.35 | 99.57% | 股权激励限售股份 | | 2021-11-03 | 75.00 | 0.09% | 83022.91 | 236.70 | 83259.61 | 100.00% | 股权激励限售流通 | | 2021-08-09 | 2617.12 | 3.14% | 82947.91 | 314.10 | 83262.01 | 100.00% | 增发A股法人配售上市 | | 2019-10-30 | 235.44 | 0.29% | 80330.80 | 235.44 | 80566.24 | 100.00% | 股权激励限售流通 | | 2018-08-08 | 329.04 | 0.41% | 80095.36 | 500.76 | 80596.12 | 100.00% | 股权激励限售流通 | | 2017-10-10 | 29988.00 | 66.96% | 44314.62 | 470.00 | 44784.62 | 100.00% | 发行前股份限售流通 | | 2016-12-05 | 2758.62 | 6.23% | 14326.62 | 29988.00 | 44314.62 | 100.00% | 增发A股法人配售上市 | | 2015-10-12 | 588.00 | 2.83% | 5784.00 | 14994.00 | 20778.00 | 100.00% | 发行前股份限售流通 |
|